(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.Date of event - estimate.The udi# is unknown because the part number and lot number was not provided.The device was not returned for evaluation because the stent remains in the patient.The reported patient effects of hypersensitivity and rash are listed in the xience alpine everolimus eluting coronary stent systems instructions for use as a known patient effects of coronary stenting procedures.A review of the lot history record and complaint history of the reported device could not be conducted because the part and lot number was not provided.A conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.However, the treatment appears to be related to the operational context of the procedure.There is no indication of a product quality issue with respect to manufacture, design or labeling.
|
Reportedly, an unknown xience alpine was implanted on (b)(6) 2015.The patient began suffering from itchiness and rashes on the arms, chest, and legs due to a suspected allergy from the implanted stent about six weeks after the stent was implanted.Cardiologist sent the patient to a dermatologist for allergy testing and all testing came back negative.The patient has taken steroids to help with the itch and rash; however, is wary about continued use because of possible medical problems.No additional information was provided.
|